Financhill
Buy
52

AVB Quote, Financials, Valuation and Earnings

Last price:
$214.60
Seasonality move :
3.97%
Day range:
$210.74 - $215.83
52-week range:
$177.40 - $239.29
Dividend yield:
3.19%
P/E ratio:
28.28x
P/S ratio:
10.49x
P/B ratio:
2.56x
Volume:
880K
Avg. volume:
701.1K
1-year change:
15.66%
Market cap:
$30.5B
Revenue:
$2.9B
EPS (TTM):
$7.59

AVB Analysts' Consensus Rating

The 19 analysts providing 12-month price projections for AvalonBay Communities shares anticipate an average target of $238.05, ranging from a low estimate of $220.00 to a high estimate of $265.00. This average target implies a growth of 10.92% compared to the current stock price of $214.62.

Consensus Price Target

$238.05

Highest Price Target

$265.00

Lowest Price Target

$220.00

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Analyst Ratings

6M Ago 1M Ago Current
Buy 4 5 5

Hold 14 14 14

Sell 0 0 0
Consensus Hold Hold Hold

AVB Recommendation Trends

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

How High Could IBIT Go?
How High Could IBIT Go?

Recently, a surprising number of billionaire hedge fund managers have…

Is Raymond James Stock a Buy, Sell or Hold?
Is Raymond James Stock a Buy, Sell or Hold?

Raymond James Financial (NYSE:RJF) is one of America’s large financial…

Is JHX Stock a Buy Sell or Hold?
Is JHX Stock a Buy Sell or Hold?

James Hardie Industries (NYSE:JHX) is a manufacturer of outside building…

Stock Ideas

Buy
56
Is AAPL Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 37x

Sell
46
Is MSFT Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 32x

Sell
41
Is NVDA Stock a Buy?

Market Cap: $2.6T
P/E Ratio: 37x

Alerts

Buy
80
CORT alert for Apr 1

Corcept Therapeutics [CORT] is up 109.21% over the past day.

Sell
47
RGC alert for Apr 1

Regencell Bioscience Holdings [RGC] is up 26.1% over the past day.

Buy
74
COOP alert for Apr 1

Mr. Cooper Group [COOP] is up 14.4% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock